Usability and feasibility of the Test of Adherence to Inhalers (TAI) Toolkit in daily clinical practice: The BANANA study-Reference-Cited by-同舟云学术

Usability and feasibility of the Test of Adherence to Inhalers (TAI) Toolkit in daily clinical practice: The BANANA study

Published:2024-05-28 Issue:1 Volume:34 Page:
ISSN:2055-1010
Container-title:npj Primary Care Respiratory Medicine
language:en
Short-container-title:npj Prim. Care Respir. Med.

Author:

Achterbosch Maria^ORCID,van de Hei Susanne J.^ORCID,Dierick Boudewijn J. H.^ORCID,Kocks Janwillem W. H.,van den Berge Maarten,Kerstjens Huib A. M.^ORCID,Been-Buck Sandra,Klemmeier Titia,van Dijk Liset,van Boven Job F. M.^ORCID

Abstract

AbstractThe Test of Adherence to Inhalers (TAI) Toolkit links an adherence measurement instrument (the TAI) to proven effective interventions for different causes of non-adherence to inhaled medication. This study aimed to assess the usability and feasibility of the TAI Toolkit in clinical practice. The TAI Toolkit was piloted in eight primary and secondary care settings. Each study site included 10 patients with asthma and/or COPD and suspected non-adherence. Healthcare professionals (HCPs) recorded clinical data and TAI Toolkit outcomes. Data on usability and feasibility were collected in semi-structured interviews and with the System Usability Score (SUS). Of the included patients, 81% were non-adherent, and sporadic non-adherence was the most common (69%). The TAI Toolkit was valued with a mean SUS-score of 85.9 by the HCPs. They found the toolkit to ‘be visually attractive’, ‘easy-to-use’ and ‘give insight into patients’ adherence’, thereby offering good potential for its use in clinical practice.

Funder

Chiesi Farmaceutici

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41533-024-00372-z.pdf

Reference33 articles.

1. Dekhuijzen, R., Lavorini, F., Usmani, O. S. & van Boven, J. F. M. Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here? J. Allergy Clin. Immunol. Pract. 6, 785–793 (2018).

2. Vestbo, J. et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 64, 939–943 (2009).

3. Mäkelä, M. J., Backer, V., Hedegaard, M. & Larsson, K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir. Med. 107, 1481–1490 (2013).

4. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action (World Health Organization, 2003).

5. Plaza, V. et al. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for asthma and COPD patients. J. Aerosol Med. Pulm. Drug Deliv. 29, 142–152 (2016).